Daniel Perkins
CEO @ Neurala Biosciences
About
Daniel is CEO of Neurala Biosciences, a University of Melbourne spin-out developing DMT-harmala therapeutics as registered treatments for mental health and addiction. He also leads the Psychedelics Research & Therapeutics Unit at the University of Melbourne and has published dozens of papers spanning pharmacological mechanisms, safety, therapeutic effects, and the regulation of psychedelic agents. A global expert on DMT-harmala therapeutics, he holds a PhD on the topic, in addition to experience in drug development, and medicines regulation as former Director of the Office of Medicinal Cannabis for the Victorian Government.
Australia
Melbourne
Biotechnology
-
Experience
CEO
Neurala Biosciences
Melbourne, Victoria, Australia
Head of the Psychedelics Research and Therapeutics Unit
University of Melbourne
Melbourne, Victoria, Australia
Adjunct Associate Professor
Swinburne University of Technology
Melbourne, Victoria, Australia
Executive Director
Psychae Institute
Melbourne, Victoria, Australia
Director Office of Medicinal Cannabis
Department of Health and Human Services
Education
University of Melbourne
University of Melbourne
University of Melbourne
Daniel Perkins's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.